Medication info

Iritol Tablet 40 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletExpired
Ingredient · strength
Atorvastatin Calcium Trihydrate›43.4mg / 1 tablet
Manufacturer / importer
Introbiopharma Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Expired

MFDS item code 202003393 · Approved 2020.05.11

This product's status changed to Expired on 2025.05.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hyperlipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who uses it
Adults
Adult dosage
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, in patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are generally similar to those in the usual adult patient population.

Ingredients

Manufacturer
Introbiopharma Co., Ltd.

Efficacy & effects

Treatment of hyperlipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • increased serum triglycerides
View approved original text

This medicine helps to reduce the risks of cardiovascular diseases. It has been shown to lower the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and in diabetic patients. It also reduces the risk of myocardial infarction, stroke, the need for vascular surgery, hospitalization for congestive heart failure, and angina in patients already suffering from heart disease. When used for the treatment of dyslipidemia, it helps to decrease cholesterol and triglycerides and increase HDL cholesterol, thus improving blood lipid levels. It is particularly effective as an adjunctive therapy in patients with various types of dyslipidemia and hyperlipidemia that are difficult to manage with diet alone. This medicine is used for the prevention of cardiovascular diseases and the treatment of hyperlipidemia.

Dosage and Administration

Adult dosage

Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, in patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are generally similar to those in the usual adult patient population.

Precautions

This medication may cause unusual muscle symptoms, so if muscle pain or weakness becomes severe, treatment should be stopped immediately and a doctor consulted. Especially in patients with poor kidney or liver function and the elderly, close monitoring for the risk of myopathy is necessary. This medication should not be taken by those who are allergic to it or have liver disease, active hepatitis, or are pregnant or breastfeeding. Additionally, it should not be given to patients with certain genetic lactose intolerance and should not be used in children under 10 years of age. Liver function may be affected, so regular liver function tests should be conducted before and during treatment. During the course of this medication, excessive alcohol should be avoided, and patients should inform their doctors if they have kidney or liver issues. This medication can interact with other drugs, so those taking other medications should inform their healthcare providers. Consuming with grapefruit juice may increase drug concentration and the risk of side effects, so caution is advised. Females taking this medication who plan to become pregnant should use appropriate contraceptives and should stop taking it immediately if pregnancy is confirmed. If symptoms such as muscle pain, fever, or fatigue occur, a doctor should be consulted immediately and blood tests should be performed. Special attention is required for children, the elderly, and patients with renal impairment when taking this medication; any adverse symptoms during treatment should be reported immediately. In case of overdose, there are no specific antidotes, so symptomatic treatment should be provided, and liver function and muscle status should be monitored through blood tests. This medication should be kept out of reach of children and stored securely in its original container.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 164 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • sensory disturbance
  • sensory loss
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • muscle pain
  • joint pain
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function test
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • post-prandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • heightened tension
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • tendon contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency of urination
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • hypothermia
  • hyperlipidemia
  • facial flushing
  • non-protein nitrogen increase
  • hyperuricemia
  • gingival hypertrophy
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • cognitive impairment
  • severe muscular weakness
  • ocular myasthenia
  • increased AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain room temperature between 1 and 30 degrees Celsius for storage. Proper storage keeps the medication effective and safe to use.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.